Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users

Objectives. A once-daily, extended-release hydrocodone bitartrate tablet with abuse-deterrent properties (Hysingla ER® [HYD]) is available for the treatment of chronic pain in appropriate patients. This study evaluated the intranasal abuse potential and pharmacokinetics of HYD coarse and fine partic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pain Med
Main Authors: Harris, Stephen C., Cipriano, Alessandra, Colucci, Salvatore V., Kapil, Ram P., Geoffroy, Pierre, Hopyan, Talar, Levy-Cooperman, Naama
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
GENERAL SECTION
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984427/
https://ncbi.nlm.nih.gov/pubmed/26814240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pm/pnv004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados